🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

62 results for “Eli Lilly and Company” Clear

  1. LY3532226

    Eli Lilly and Company

    Obesity

    phase 1 small molecule completed

    1 trial

  2. LY3537021

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial

  3. LY3819469

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial

  4. LY4006896

    Eli Lilly and Company

    Parkinson Disease

    phase 1 small molecule active

    1 trial

  5. Olaratumab

    Eli Lilly and Company

    Malignancy

    phase 1 mab completed

    1 trial

  6. Olomorasib

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial

  7. Tabalumab

    Eli Lilly and Company

    Multiple Myeloma

    phase 1 mab completed

    1 trial

  8. Tirzepatide

    Eli Lilly and Company

    Healthy

    phase 1 small molecule completed

    1 trial

  9. Abemaciclib

    Eli Lilly and Company

    Breast Neoplasms

    approved small molecule completed

    1 trial

  10. Abemaciclib

    Eli Lilly and Company

    Metastatic Breast Cancer

    approved small molecule terminated

    1 trial

  11. Insulin Glargine

    Eli Lilly and Company

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  12. Insulin lispro low mixture

    Eli Lilly and Company

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  13. premeal insulin lispro mixtures

    Eli Lilly and Company

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  14. Propranolol

    Eli Lilly and Company

    Healthy

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources